|
1
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Roy S and Majumdar AP: Signaling in colon
cancer stem cells. J Mol Signal. 7:112012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Markowitz SD and Bertagnolli MM: Molecular
origins of cancer: Molecular basis of colorectal cancer. N Engl J
Med. 361:2449–2460. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Clarke MF, Dick JE, Dirks PB, Eaves CJ,
Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM: Cancer
stem cells-perspectives on current status and future directions.
Cancer Res. 166:9339–9344. 2006. View Article : Google Scholar
|
|
5
|
Ponti D, Zaffaroni N, Capelli C and
Daidone MG: Breast cancer stem cells: An overview. Eur J Cancer.
42:1219–1224. 2006. View Article : Google Scholar
|
|
6
|
Fan CW, Chen T, Shang YN, Gu YZ, Zhang SL,
Lu R, OuYang SR, Zhou X, Li Y, Meng WT, et al: Cancer-initiating
cells derived from human rectal adenocarcinoma tissues carry
mesenchymal phenotypes and resist drug therapies. Cell Death Dis.
4:e8282013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang L, Jiao M, Li L, Wu D, Wu K, Li X,
Zhu G, Dang Q, Wang X, Hsieh JT and He D: Tumorspheres derived from
prostate cancer cells possess chemoresistant and cancer stem cell
properties. J Cancer Res Clin Oncol. 138:675–686. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Puglisi MA, Barba M, Corbi M, Errico MF,
Giorda E, Saulnier N, Boninsegna A, Piscaglia AC, Carsetti R,
Cittadini A, et al: Identification of Endothelin-1 and NR4A2 as
CD133-regulated genes in colon cancer cells. J Pathol. 225:305–314.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jones RJ, Matsui WH and Smith BD: Cancer
stem cells: Are we missing the target? J Natl Cancer Inst.
96:583–585. 2004. View Article : Google Scholar
|
|
10
|
Wang L, Guo H, Yang L, Dong L, Lin C,
Zhang J, Lin P and Wang X: Morusin inhibits human cervical cancer
stem cell growth and migration through attenuation of NF-κB
activity and apoptosis induction. Mol Cell Biochem. 379:7–18. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fu Y, Chang H, Peng X, Bai Q, Yi L, Zhou
Y, Zhu J and Mi M: Resveratrol inhibits breast cancer stem-like
cells and induces autophagy via suppressing Wnt/β-catenin signaling
pathway. PLoS One. 9:e1025352014. View Article : Google Scholar
|
|
12
|
Li Y and Zhang T: Targeting cancer stem
cells by curcumin and clinical applications. Cancer Lett.
346:197–205. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee YJ, Chang CF, Lin CW, Huang YC, Hu CC,
Tsheng YM and Tseng TH: The first total synthesis of morusin and
himanimide D as arachidonate 5-lipoxygenase inhibitor in automated
docking. Biophys J. 96(Suppl 1): 86A2009. View Article : Google Scholar
|
|
14
|
Lee JC, Won SJ, Chao CL, Wu FL, Liu HS,
Ling P, Lin CN and Su CL: Morusin induces apoptosis and suppresses
NF-κB activity in human colorectal cancer HT-29 cells. Biochem
Biophys Res Commun. 372:236–242. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wan LZ, Ma B and Zhang YQ: Preparation of
morusin from Ramulus mori and its effects on mice with transplanted
H22 hepatocarcinoma. Biofactors. 40:636–645. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ma JP, Qiao X, Pan S, Shen H, Zhu GF and
Hou AJ: New isoprenylated flavonoids and cytotoxic constituents
from Artocarpus tonkinensis. J Asian Nat Prod Res. 12:586–592.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee HJ, Lyu da H, Koo U, Nam KW, Hong SS,
Kim KO, Kim KH, Lee D and Mar W: Protection of prenylated
flavonoids from Mori Cortex Radicis (Moraceae) against nitric
oxide-induced cell death in neuroblastoma SH-SY5Y cells. Arch Pharm
Res. 35:163–170. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vermeulen L, De Sousa E, Melo F, van der
Heijden M, Cameron K, de Jong JH, Borovski T, Tuynman JB, Todaro M,
Merz C, Rodermond H, et al: Wnt activity defines colon cancer stem
cells and is regulated by the microenvironment. Nat Cell Biol.
12:468–476. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kanwar SS, Yu Y, Nautiyal J, Patel BB and
Majumdar AP: The Wnt/beta-catenin pathway regulates growth and
maintenance of colonospheres. Mol Cancer. 9:2122010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li YF, Xiao B, Tu SF, Wang YY and Zhang
XL: Cultivation and identification of colon cancer stem
cell-derived spheres from the Colo205 cell line. Braz J Med Biol
Res. 45:197–204. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ohigashi T, Mizuno R, Nakashima J, Marumo
K and Murai M: Inhibition of Wnt signaling downregulates Akt
activity and induces chemosensitivity in PTEN-mutated prostate
cancer cells. Prostate. 62:61–68. 2005. View Article : Google Scholar
|
|
23
|
Sutton LP and Rushlow WJ: Regulation of
Akt and Wnt signaling by the group II metabotropic glutamate
receptor antagonist LY341495 and agonist LY379268. J Neurochem.
117:973–983. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jain MV, Jangamreddy JR, Grabarek J,
Schweizer F, Klonisch T, Cieślar-Pobuda A and Łos MJ: Nuclear
localized Akt enhances breast cancer stem-like cells through
counter-regulation of p21(Waf1/Cip1) and p27(kip1). Cell Cycle.
14:2109–2120. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chowdhury R, Chatterjee R, Giri AK, Mandal
C and Chaudhuri K: Arsenic-induced cell proliferation is associated
with enhanced ROS generation, Erk signaling and CyclinA expression.
Toxicol Lett. 198:263–271. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dallas NA, Xia L, Fan F, Gray MJ, Gaur P,
van Buren G II, Samuel S, Kim MP, Lim SJ and Ellis LM:
Chemoresistant colorectal cancer cells, the cancer stem cell
phenotype, and increased sensitivity to insulin-like growth
factor-I receptor inhibition. Cancer Res. 69:1951–1957. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Paldino E, Tesori V, Casalbore P,
Gasbarrini A and Puglisi MA: Tumor initiating cells and
chemoresistance: Which is the best strategy to target colon cancer
stem cells? Biomed Res Int. 2014:8598712014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Burnett J, Newman B and Sun D: Targeting
cancer stem cells with natural products. Curr Drug Targets.
13:1054–1064. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bao B, Li Y, Ahmad A, Azmi AS, Bao G, Ali
S, Banerjee S, Kong D and Sarkar FH: Targeting CSC-related miRNAs
for cancer therapy by natural agents. Curr Drug Targets.
13:1858–1868. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Levings PP, McGarry SV, Currie TP,
Nickerson DM, McClellan S, Ghivizzani SC, Steindler DA and Gibbs
CP: Expression of an exogenous human Oct-4 promoter identifies
tumor-initiating cells in osteosarcoma. Cancer Res. 69:5648–5655.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shan J, Shen J, Liu L, Xia F, Xu C, Duan
G, Xu Y, Ma Q, Yang Z, Zhang Q, et al: Nanog regulates self-renewal
of cancer stem cells through the insulin-like growth factor pathway
in human hepatocellular carcinoma. Hepatology. 56:1004–1014. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Merlos-Suárez A, Barriga FM, Jung P,
Iglesias M, Céspedes MV, Rossell D, Sevillano M, Hernando-Momblona
X, da Silva-Diz V, Muñoz P, et al: The intestinal stem cell
signature identifies colorectal cancer stem cells and predicts
disease relapse. Cell Stem Cell. 8:511–524. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen RH, Ding WV and McCormick F: Wnt
signaling to beta-catenin involves two interactive components
glycogen synthase kinase-3beta inhibition and activation of protein
kinase C. J Biol Chem. 275:17894–17899. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Prasetyanti PR, Zimberlin CD, Bots M,
Vermeulen L, Melo Fde S and Medema JP: Regulation of stem cell
self-renewal and differentiation by Wnt and Notch are conserved
throughout the adenoma-carcinoma sequence in the colon. Mol Cancer.
12:1262013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shenoy AK, Fisher RC, Butterworth EA, Pi
L, Chang LJ, Appelman HD, Chang M, Scott EW and Huang EH:
Transition from colitis to cancer: High Wnt activity sustains the
tumor-initiating potential of colon cancer stem cell precursors.
Cancer Res. 72:5091–5100. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li Y, Welm B, Podsypanina K, Huang S,
Chamorro M, Zhang X, Rowlands T, Egeblad M, Cowin P, Werb Z, et al:
Evidence that transgenes encoding components of the Wnt signaling
pathway preferentially induce mammary cancers from progenitor
cells. Proc Natl Acad Sci USA. 100:15853–15858. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ibrahim EE, Babaei-Jadidi R, Saadeddin A,
Spencer-Dene B, Hossaini S, Abuzinadah M, Li N, Fadhil W, Ilyas M,
Bonnet D and Nateri AS: Embryonic NANOG activity defines colorectal
cancer stem cells and modulates through AP1-and TCF-dependent
mechanisms. Stem cells. 30:2076–2087. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li J, Li J and Chen B: Oct4 was a novel
target of Wnt signaling pathway. Mol Cell Biochem. 362:233–240.
2012. View Article : Google Scholar
|
|
39
|
Zhang Y, Liu C, Duan X, Ren F, Li S, Jin
Z, Wang Y, Feng Y, Liu Z and Chang Z: CREPT/RPRD1B, a recently
identified novel protein highly expressed in tumors, enhances the
β-catenin·TCF4 transcriptional activity in response to Wnt
signaling. J Biol Chem. 289:22589–22599. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Dang CV: MYC on the path to cancer. Cell.
149:22–35. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kelly RJ, Lopez-Chavez A, Citrin D, Janik
JE and Morris JC: Impacting tumor cell-fate by targeting the
inhibitor of apoptosis protein survivin. Mol Cancer. 10:352011.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Diaz-Moralli S, Tarrado-Castellarnau M,
Miranda A and Cascante M: Targeting cell cycle regulation in cancer
therapy. Pharmacol Ther. 138:255–271. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang ML, Chiou SH and Wu CW: Targeting
cancer stem cells: Emerging role of Nanog transcription factor.
Onco Targets Ther. 6:1207–1220. 2013.PubMed/NCBI
|
|
44
|
Choi SC, Choi JH, Park CY, Ahn CM, Hong SJ
and Lim DS: Nanog regulates molecules involved in stemness and cell
cycle-signaling pathway for maintenance of pluripotency of P19
embryonal carcinoma stem cells. J Cell Physiol. 227:3678–3692.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhou BP, Liao Y, Xia W, Spohn B, Lee MH
and Hung MC: Cytoplasmic localization of p21 Cip1/WAF1 by
Akt-induced phosphorylation in HER-2/neu-overexpressing cells.
Nature Cell Biol. 3:245–252. 2001. View Article : Google Scholar
|
|
46
|
Engelman JA, Luo J and Cantley LC: The
evolution of phosphatidylinositol 3-kinases as regulators of growth
and metabolism. Nat Rev Genet. 7:606–619. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zheng X, Wang Y, Liu B, Liu C, Liu D, Zhu
J, Yang C, Yan J, Liao X, Meng X and Yang H: Bmi-1-shRNA inhibits
the proliferation of lung adenocarcinoma cells by blocking the G1/S
phase through decreasing cyclin D1 and increasing p21/p27 levels.
Nucleic Acid Ther. 24:210–216. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Xie J, Xiang DB, Wang H, Zhao C, Chen J,
Xiong F, Li TY and Wang XL: Inhibition of Tcf-4 induces apoptosis
and enhances chemosensitivity of colon cancer cells. PLoS One.
7:e456172012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Asada M, Yamada T, Ichijo H, Delia D,
Miyazono K, Fukumuro K and Mizutani S: Apoptosis inhibitory
activity of cytoplasmic p21(Cip1/WAF1) in monocytic
differentiation. EMBO J. 18:1223–1234. 1999. View Article : Google Scholar : PubMed/NCBI
|
